At present, the only flaviviral vaccines available for human use are yellow fever (live attenuated), Japanese encephalitis (inactivated, live attenuated, and chimeric), tick-borne encephalitis (inactivated) vaccines, and the newly marketed dengue vaccine (live attenuated, recombinant, tetravalent; marketed since 2015).
Claims were made by an Indian biotechnology company that two Zika virus vaccine candidates (recombinant and inactivated) can be tested soon; however, no details on the vaccine preparations are currently available in the scientific literature.
In any case, a normal vaccine development cycle usually requires years of preclinical and clinical studies and a Zika virus vaccine for human use is unlikely to be available in the near future.
1,ScienceAlert. An Indian company says they have two Zika vaccine candidates ready for pre-clinical trials. Available at: http://www.sciencealert.com/an-indian-company-saysthey-have-2-zika-vaccines-ready-for-pre-clinical-trials.
2,Wong SS-Y, et al., Zika virus infectiondthe next wave after dengue?, Journal of the Formosan Medical Association (2016), http://dx.doi.org/10.1016/j.jfma.2016.02.002